Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.

Abstract

BACKGROUND Toremifene is a new antiestrogen, which in nonclinical studies appears less carcinogenic than tamoxifen. Clinical trials of adjuvant toremifene vs. tamoxifen in breast cancer patients are ongoing. This study aimed to evaluate the short-term effects of changing from adjuvant tamoxifen to toremifene. PATIENTS AND METHODS Twenty postmenopausal… (More)

Topics

Cite this paper

@article{Bertelli2000ToremifeneAA, title={Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.}, author={Guilherme Bertelli and P. J. Queirolo and Sabine Vecchio and Claudia Angiolini and Marina Bergaglio and Lucia Del Mastro and Alessandra Signorini and Mario Valenzano and M. C. Venturini}, journal={Anticancer research}, year={2000}, volume={20 5C}, pages={3659-61} }